The abandoned trials of pre-exposure prophylaxis for HIV: what went wrong?
about
Grand challenges in global health: community engagement in research in developing countriesWe must not let protestors derail trials of pre-exposure prophylaxis for HIVGrand challenges in global health: engaging civil society organizations in biomedical research in developing countriesGrand challenges in global health: the ethical, social and cultural programThe tenofovir pre-exposure prophylaxis trial in Thailand: researchers should show more openness in their engagement with the communityThe spread, treatment, and prevention of HIV-1: evolution of a global pandemicMedia reporting of tenofovir trials in Cambodia and Cameroon.Enrolling women into HIV preventive vaccine trials: an ethical imperative but a logistical challenge.A pill for HIV prevention: déjà vu all over again?Pre-exposure prophylaxis of HIVHIV pre-exposure prophylaxis (PrEP)--a quantitative ethics appraisalDesigning research in vulnerable populations: lessons from HIV prevention trials that stopped early.Ethical and regulatory issues surrounding African traditional medicine in the context of HIV/AIDS.Developing a Framework for Evaluating Ethical Outcomes of Good Participatory Practices in TB Clinical Drug TrialsCommunity engagement in biomedical research in an African setting: the Kintampo Health Research Centre experienceLegal and ethical values in the resolution of research-related disputes: how can IRBS respond to participant complaints?Paying for prevention: challenges to health insurance coverage for biomedical HIV prevention in the United States.Improving ethical and participatory practice for marginalized populations in biomedical HIV prevention trials: lessons from Thailand.How ethical is your clinical trial?Role of the pharmacist in pre-exposure chemoprophylaxis (PrEP) therapy for HIV prevention.Getting to zero the biomedical way in Africa: outcomes of deliberation at the 2013 Biomedical HIV Prevention Forum in Abuja, Nigeria.Tracking the mutual shaping of the technical and social dimensions of solar-powered mosquito trapping systems (SMoTS) for malaria control on Rusinga Island, western Kenya.Addressing ethical, social, and cultural issues in global health research'Who is Helsinki?' Sex workers advise improving communication for good participatory practice in clinical trialsPre-exposure prophylaxis of HIV: A right way to go or a long way to go?Getting personal: ethics and identity in global health research.Ethical challenges in the design and conduct of locally relevant international health researchTowards a Science of Community Stakeholder Engagement in Biomedical HIV Prevention Trials: An Embedded Four-Country Case Study.Stakeholder Engagement in HIV Cure Research: Lessons Learned from Other HIV Interventions and the Way Forward.The promises and challenges of pre-exposure prophylaxis as part of the emerging paradigm of combination HIV preventionTranslating PrEP effectiveness into public health impact: key considerations for decision-makers on cost-effectiveness, price, regulatory issues, distributive justice and advocacy for access.West African Bioethics Training Program: Raison D'être.Correlates of condom use among female sex workers in The Gambia: results of a cross-sectional survey.Antiretroviral agents used by HIV-uninfected persons for prevention: pre- and postexposure prophylaxis.Assessing Clinical Research Capacity in Vietnam: A Framework for Strengthening Capability for Clinical Trials in Developing Countries.Ethics and the ethnography of medical research in Africa.PrEP: controversy, agency and ownership.The Significance of Benefit Perceptions for the Ethics of HIV Research Involving Adolescents in Kenya.Knowledge and acceptability of alternative HIV prevention bio-medical products among MSM who bareback.The exploitation of "Exploitation" in the tenofovir prep trial in Cameroon: Lessons learned from media coverage of an HIV prevention trial.
P2860
Q21092370-72F7BE69-82A2-41F2-BDD2-79541279533BQ21092391-314D4BCE-CAE8-4500-A24F-F7034F945212Q21563413-05771288-8DCF-4DB8-9817-5EB1762E7ECEQ21563419-80BB4EBE-3807-48C8-AA94-3A3E2FB3E56DQ21563441-D34C3030-31B3-484D-ACC5-F720DD9E8A97Q22241890-01D85CB8-D26F-456D-B4F9-B76170B81938Q24814276-A9274627-C2C4-4561-A11C-BA905EF769CCQ25255907-6761CAD2-7F61-4108-95B4-D7B1CFD9DC34Q26824606-94FEFB5F-C645-4273-887E-BB5B84E05C9AQ28244364-63DCE9D8-1C42-4E23-AA82-DC2EB5956EFFQ28741736-DA394FD9-6932-4EC7-AEFF-87D30BE15DB3Q30476516-9B43F5CE-E70A-4520-9E42-0AA0181B25C5Q33278129-43D0C236-034B-4CD2-9CB6-B5F05B1035E0Q33557271-4601C987-56AA-4D28-BEEF-09FA4578BCA6Q33590277-9E1E9CFC-B087-481F-BE8D-86E88B3C8226Q33696526-1CA4BF01-C465-4B36-839E-C4E7202EECF0Q33696533-C156FD4C-8022-4FE5-A17B-331193183CD4Q33783865-5CDBA533-6BEE-4CEA-A30D-51265646935CQ34044823-86F07649-BF6D-4110-8597-8564694D22F3Q34072076-567FEF8C-89A2-4E7D-858F-9D4101957639Q34196941-5C142A92-9AE6-4A15-B30E-CA1244DB6ACBQ34539481-0CDB1401-4E80-40D1-9113-EE1BDA461739Q34952236-D9688769-1019-4590-B133-3ECE73C924E7Q34996417-6B4C8764-B847-4E65-B174-ACB16D137920Q35033732-27C80945-993B-4C9A-9D06-771551134EA0Q35131983-9A54D1DB-B1E4-4279-B0E1-01B04E41FA54Q35642117-4790BBE5-2858-4A91-A70E-61B67B8034F1Q35752023-9D4E462B-3787-4783-A517-3F257FF59442Q35857623-6CC83570-08CD-4E96-AED3-D15C8B6429C7Q35875723-74A5DFF4-FF7A-4CE6-87AB-9B063C5ADF74Q35875746-31DB9FFA-E3AC-45A1-A908-50FB6D9C3EB0Q35912954-668DB05F-9DBE-4523-8376-89C98B8CB97BQ35965521-A8E5D152-2F09-460B-9D0F-70ACEC748508Q36873010-B6E57E47-A42B-43A8-A33B-AB8050C86D34Q36906767-00491744-61BE-40CE-9FBF-BF23CA3615B6Q37154151-8F2E11EC-AF22-4997-A2BF-B2CEA1749700Q37352489-99303212-E3ED-49AA-AE80-180FEF4D1CAFQ38654279-19B7CD3D-F5BE-404F-802E-1D3800F389B9Q40123390-D057E26C-A707-4C74-974D-741CF3F4398FQ43009532-038B619D-1D70-4B4E-8364-51BF35AB62C5
P2860
The abandoned trials of pre-exposure prophylaxis for HIV: what went wrong?
description
2005 nî lūn-bûn
@nan
2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
The abandoned trials of pre-exposure prophylaxis for HIV: what went wrong?
@ast
The abandoned trials of pre-exposure prophylaxis for HIV: what went wrong?
@en
The abandoned trials of pre-exposure prophylaxis for HIV: what went wrong?
@en-gb
The abandoned trials of pre-exposure prophylaxis for HIV: what went wrong?
@nl
type
label
The abandoned trials of pre-exposure prophylaxis for HIV: what went wrong?
@ast
The abandoned trials of pre-exposure prophylaxis for HIV: what went wrong?
@en
The abandoned trials of pre-exposure prophylaxis for HIV: what went wrong?
@en-gb
The abandoned trials of pre-exposure prophylaxis for HIV: what went wrong?
@nl
altLabel
The Abandoned Trials of Pre-Exposure Prophylaxis for HIV: What Went Wrong?
@en
prefLabel
The abandoned trials of pre-exposure prophylaxis for HIV: what went wrong?
@ast
The abandoned trials of pre-exposure prophylaxis for HIV: what went wrong?
@en
The abandoned trials of pre-exposure prophylaxis for HIV: what went wrong?
@en-gb
The abandoned trials of pre-exposure prophylaxis for HIV: what went wrong?
@nl
P2860
P3181
P1433
P1476
The abandoned trials of pre-exposure prophylaxis for HIV: what went wrong?
@en
P2093
Edward J Mills
Jerome A Singh
P2860
P3181
P356
10.1371/JOURNAL.PMED.0020234
P407
P577
2005-07-19T00:00:00Z